TCON TRACON Pharmaceuticals, Inc: Bozor kapitallashuvining balans qiymatiga nisbati

TCON (traconpharma.com) - kompaniyaning tovar belgisi

Tijorat mahsulotlarining yo'qligi va tashqi moliyalashtirishga bog'liqlik xatarlari TRACON Pharmaceuticals (TCON) aktivlarini optimallashtirishga bo'lgan bozorning pragmatik ishonchi bilan zid keladi. Bozor kapitalizatsiyasining buxgalteriya qiymatiga nisbati o'zgarishi ushbu ziddiyatni hal qiladi va oxirgi ko'rsatkich -0.09 ni tashkil etadi. Biznes modeli molekulalar sintezi va sinovlarini to'liq autsorsing qilishga asoslangan bo'lib, bu esa shaxsiy ishlab chiqarish zavodlariga bo'lgan ehtiyojni bartaraf etadi.

TRACON Pharmaceuticals, Inc (TCON): Kapitallashuvning balans qiymatiga nisbati 04.07.2022dan 04.08.2024gacha
TRACON seriyali mahsuloti

TRACON Pharmaceuticals (TCON) klinik dasturlaridagi turg'unlik moddiy aktivlarni baholashni juda muhim qiladi. Ushbu koeffitsient aksiyalarning bozor qiymatini sof kapital bilan solishtirib, investorlarning kompaniya uchun qanchalik ortiqcha to'lov qilayotganini ochib beradi. Ushbu metrika kapitalning xavfsizlik zaxirasini belgilaydi va agar baholashlar shishirilgan bo'lsa, potensial inqiroz xavfi haqida signal beradi. Tahlil pipeline qayta tashkil etilishi bo'yicha kutishlar asosli ekanligini aniqlashga yordam beradi. Narxning buxgalteriya qiymatiga nisbati tendentsiyasini o'rganish orqali xavfsiz kirish nuqtalarini aniqlash mumkin.

Raqobatchilar tahlili

Bozor qiymatining balans qiymatiga nisbati Tempus Labs|qiagen.com (QGEN) - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Ionis (IONS)|Kapitallashuvning balans qiymatiga nisbati RGEN|Bozor qiymatining balans qiymatiga nisbati Avidity RNA|Kapitallashuvning balans qiymatiga nisbati CRISPR (CRSP)|Bozor kapitallashuvining balans qiymatiga nisbati WGS (GeneDx Holdings Corp.)|RARE - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Beam Therapeutics BEAM|SRPT: Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor qiymatining balans qiymatiga nisbati Twist Bio TWST|10x (TXG) - Balans qiymatiga nisbatan bozor qiymati|NTLA (Intellia Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati stoketherapeutics.com|Bozor kapitallashuvining balans qiymatiga nisbati BLFS (BioLife Solutions)|Kapitallashuvning sof aktivlarga nisbati WVE (Wave Life Sciences Ltd)|MAZE: Bozor qiymatining balans qiymatiga nisbati|Sionna Corp - Bozor qiymatining balans qiymatiga koeffitsiyenti|Prime Medicine, Inc. (PRME) - Bozor qiymatining balans qiymatiga nisbati|tayshagtx.com (TSHA) - Kapitallashuvning balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati uniQure QURE|MGTX (MeiraGTx Holdings) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Regenxbio RGNX|Sof aktivlarga nisbatan bozor kapitallashuvi Solid Corp|Ocugen, Inc. (OCGN) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati pacb.com (PACB)|Bozor kapitallashuvining balans qiymatiga nisbati BNTC (Benitec Biopharma)|Design Therapeutics Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Rocket Pharmaceuticals Inc (RCKT)|FDMT: Balans qiymatiga nisbatan bozor qiymati|LXEO (lexeotx.com) - Bozor qiymatining balans qiymatiga nisbati|Korro Bio (KRRO) - Kapitallashuvning sof aktivlarga nisbati|EDIT (Editas Medicine) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Silence Therapeutics PLC|Bozor kapitallashuvining balans qiymatiga nisbati PRQR (ProQR Therapeutics N.V.)|Kapitallashuvning sof aktivlarga nisbati codexis.com (CDXS)|SGMO: Bozor kapitallashuvining balans qiymatiga nisbati|NAUT - Bozor qiymatining balans qiymatiga koeffitsiyenti|Metagenomi - Kapitallashuvning sof aktivlarga nisbati|precisionbiosciences.com (DTIL) - Bozor kapitallashuvining balans qiymatiga nisbati|GBIO - Kapitallashuvning sof aktivlarga nisbati|Boundless Bio Inc (BOLD) - Bozor kapitallashuvining balans qiymatiga multiplikatori|XCUR: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Celsion Corporation|Bozor kapitallashuvining balans qiymatiga nisbati PHIO (Phio Pharmaceuticals)|Kapitallashuvning sof aktivlarga nisbati mustangbio.com (MBIO)|Bozor kapitallashuvining balans qiymatiga nisbati RNAZ (TransCode Therapeutics, Inc.)|Bionano Genomics Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|APDN - Bozor qiymatining balans qiymatiga nisbati|BLUE: Bozor qiymatining balans qiymatiga nisbati|immunoprecise.com - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Omega Therapeutics Inc|Singular Genomics Systems Inc (OMIC) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori Regulus|Bozor kapitallashuvining balans qiymatiga nisbati SYRS (Syros Pharmaceuticals)|Kapitallashuvning sof aktivlarga nisbati TBIO (telesisbio.com)|UBX: Bozor qiymatining balans qiymatiga nisbati